SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

Search

LISI.

Cerrado

SectorAcciones industriales

50.6 -0.39

Resumen

Variación precio

24h

Actual

Mínimo

48.95

Máximo

50.8

Métricas clave

By Trading Economics

Ingresos

-14M

25M

Ventas

-240M

769M

P/B

Media del Sector

36.654

61.065

Rentabilidad por dividendo

0.93

Margen de beneficios

3.22

Empleados

9,537

EBITDA

-33M

106M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+25.38% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.93%

2.23%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-565M

2.3B

Apertura anterior

50.99

Cierre anterior

50.6

Noticias sobre sentimiento de mercado

By Acuity

21%

79%

52 / 406 Clasificación en Industrials

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

LISI. Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

23 mar 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar 2026, 22:55 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar 2026, 21:51 UTC

Adquisiciones, fusiones, absorciones

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar 2026, 23:59 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

23 mar 2026, 23:59 UTC

Charlas de Mercado

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar 2026, 23:50 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar 2026, 23:37 UTC

Charlas de Mercado

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar 2026, 22:42 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Global Equities Roundup: Market Talk

23 mar 2026, 22:42 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar 2026, 22:40 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar 2026, 22:23 UTC

Charlas de Mercado

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar 2026, 22:22 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar 2026, 22:21 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar 2026, 22:21 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar 2026, 22:20 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar 2026, 22:20 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar 2026, 22:19 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar 2026, 22:19 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar 2026, 22:18 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar 2026, 22:15 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar 2026, 22:08 UTC

Charlas de Mercado

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar 2026, 21:42 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

23 mar 2026, 21:42 UTC

Charlas de Mercado

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar 2026, 21:32 UTC

Ganancias

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar 2026, 21:32 UTC

Ganancias

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar 2026, 21:32 UTC

Ganancias

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar 2026, 21:10 UTC

Noticias de Eventos Importantes

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar 2026, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

23 mar 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

23 mar 2026, 20:50 UTC

Charlas de Mercado
Ganancias
Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

Comparación entre iguales

Cambio de precio

LISI. previsión

Precio Objetivo

By TipRanks

25.38% repunte

Estimación a 12 Meses

Media 62 EUR  25.38%

Máximo 62 EUR

Mínimo 62 EUR

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para LISI. Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

1

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

27.7 / 28.3Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

52 / 406 Clasificación en Acciones industriales

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de LISI.

Lisi S.A. provides assembly and component solutions for the aerospace, automotive, and medical sectors in France and internationally. It operates through three divisions: LISI Aerospace, LISI Automotive, and LISI Medical. The company offers aeronautic fastener solutions; structural components and parts for aircraft, helicopters, and airplanes; air conditioning and pressurization products, actuation and power components, helicopter rotors, landing gear structures, tanks and accumulators, and wheels and brakes; fan blades, outlet guide vanes, compressor blades, fixed vanes, variable vanes, disks, blisks, impellers, gears, inner and outer rings, and housings, as well as accessories and equipment, hot and cold section products for jet engines and turboshafts; and defense and space products. It also provides threaded fasteners, including screws, bolts, nuts, washers, special parts, etc. for industrial and automotive systems; clipped solutions, such as panel and trim fasteners, clipped nuts and screws, fasteners and connectors for cables and tubes, anti-creep rings, etc.; and braking systems, seating, occupant safety systems, fuel system components, etc. In addition, the company offers reconstruction implants and instruments, and spine and orthopedic implants; components and instruments for manual or robotic mini-invasive surgery; and components for laparoscopy, endoscopy, cardiovascular, neuro-cerebral surgery, etc. The company was formerly known as GFI Industries and changed its name to Lisi S.A. in 2002. The company was founded in 1777 and is headquartered in Belfort, France.
help-icon Live chat